**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: February 12, 1985
* Admitting Date: March 10, 2023
* Discharge Date: March 20, 2023

**Chief Complaint:**

The patient was admitted to the endocrinology unit with a chief complaint of increased thirst and urination, as well as blurred vision, over the past 2 weeks.

**History of Present Illness:**

The patient's symptoms began approximately 2 weeks prior to admission, with increasing thirst and urination, followed by blurred vision. He reported no significant changes in his diet or exercise routine.

**Past Medical History:**

The patient has no significant past medical history, except for a 20-pack-year history of smoking, which he quit 5 years ago. He has no known allergies.

**Physical Examination:**

Upon admission, the patient's physical examination was notable for a blood pressure of 140/90 mmHg, pulse of 80 beats per minute, and body mass index (BMI) of 32.5 kg/mÂ². He had no obvious signs of diabetic retinopathy, nephropathy, or neuropathy.

**Laboratory Results:**

The patient's laboratory results showed the following:

* Fasting plasma glucose (FPG): 240 mg/dL (13.3 mmol/L)
* Glycosylated hemoglobin (HbA1C): 7.8%
* Random glucose value: 220 mg/dL (12.2 mmol/L)

**Diagnosis:**

Based on the patient's laboratory results and physical examination, he was diagnosed with type 2 diabetes mellitus.

**Treatment:**

The patient was started on metformin 500 mg twice daily and was instructed to follow a personalized diet and exercise plan. He was also educated on the importance of monitoring his blood glucose levels and adjusting his insulin doses based on his readings.

**Medications:**

* Metformin 500 mg twice daily
* Aspirin 81 mg once daily (for cardiovascular prophylaxis)

**Dietary Recommendations:**

The patient was advised to follow a personalized diet that focuses on whole foods and high-quality carbohydrates, accommodating his requirements posed by comorbid conditions. He was also educated on the importance of carbohydrate counting and adjusting his insulin doses based on his carbohydrate intake.

**Exercise Plan:**

The patient was advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk. He was also instructed to incorporate resistance exercises 2-3 times per week.

**Patient Education:**

The patient was extensively educated on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also instructed on how to adjust his insulin doses based on his blood glucose levels and carbohydrate intake.

**Follow-up:**

The patient is scheduled for a follow-up appointment with his primary care physician in 2 weeks to monitor his blood glucose control and adjust his treatment plan as needed.

**Additional Recommendations:**

* The patient should be vaccinated against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2.
* The patient should be referred to a professional podiatrist for regular foot care.
* The patient should be educated on the importance of regular monitoring for diabetic complications, including foot and funduscopic examinations, urine testing for albuminuria, and measurement of serum creatinine and lipid profile.

**Discharge Instructions:**

The patient was discharged with the following instructions:

* Take metformin 500 mg twice daily as directed.
* Follow the personalized diet plan.
* Engage in at least 150 minutes of moderate-intensity aerobic exercise per week.
* Monitor his blood glucose levels regularly and adjust his insulin doses as needed.
* Attend follow-up appointments as scheduled.
* Report any signs or symptoms of hypoglycemia or hyperglycemia to his primary care physician.

**Signature:**

I, [Your Name], MD, hereby certify that I have reviewed the patient's medical chart and confirm that the above information is accurate and complete.

Signature: ______________________________ Date: ______________________________